All Articles tagged Greece

• Oncology
  February 17, 2022 EDT
  Cost-effectiveness Analysis of Lorlatinib in Patients Previously Treated with Anaplastic Lymphoma Kinase Inhibitors for Non-small Cell Lung Cancer in Greece
  George GourzoulidisOresteia ZisimopoulouNadia BoubouchairopoulouChristina MichailidiChrissy LowryCharalampos TzanetakosGeorgia Kourlaba

  The present study assessed the cost-effectiveness of lorlatinib versus pemetrexed with platinum combination of carboplatin or cisplatin (P-ChT) in Greece.

  Abstract